{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:16Z","timestamp":1792611676529,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.contraception.2025.110869","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T12:34:48Z","timestamp":1743251688000},"page":"110869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 3 \u2013\u00a0Skin, blood, gastrointestinal, liver, lung, central nervous system, and other cancers: Joint with the Society of Gynecologic Oncology"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-2105","authenticated-orcid":false,"given":"Pelin","family":"Batur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor Bimla","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.110869_bib1","unstructured":"Batur P., Brant A., McCourt C., Schwarz E.B. Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 1 - Key considerations for clinical care. Contraception n.d."},{"key":"10.1016\/j.contraception.2025.110869_bib2","unstructured":"Batur P., Brant A., McCourt C., Schwarz E.B. Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 - Breast, ovarian, uterine, and cervical cancer. Contraception n.d."},{"key":"10.1016\/j.contraception.2025.110869_bib3","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1468-3083.2010.03638.x","article-title":"Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis","volume":"24","author":"Jang","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.contraception.2025.110869_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijwd.2021.06.005","article-title":"Hormone therapy and melanoma in women","volume":"7","author":"Hill","year":"2021","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.contraception.2025.110869_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12253-018-00569-x","article-title":"Hormone replacement therapy in cancer survivors \u2013 review of the literature","volume":"26","author":"Deli","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.contraception.2025.110869_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4183\/aeb.2016.234","article-title":"The role of estrogens and estrogen receptors in melanoma development and progression","volume":"12","author":"Caruntu","year":"2016","journal-title":"Acta Endo (Buc)"},{"key":"10.1016\/j.contraception.2025.110869_bib7","first-page":"669","article-title":"Pregnancy and melanoma","volume":"75","author":"Driscoll","year":"2016","journal-title":"J\u00a0Am\u00a0Acad\u00a0Dermatol"},{"key":"10.1016\/j.contraception.2025.110869_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.bjc.6690787","article-title":"Oral contraceptive use and risk of melanoma in premenopausal women","volume":"81","author":"Feskanich","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib9","first-page":"2607","article-title":"Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis","volume":"47","author":"Gandini","year":"2011","journal-title":"Eur\u00a0J\u00a0Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2147\/CLEP.S273566","article-title":"Effects of exogenous hormones and reproductive factors on female melanoma: a meta-analysis","volume":"12","author":"Sun","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib11","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.31644","article-title":"Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study","volume":"143","author":"Cervenka","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib12","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1038\/s41598-021-88077-y","article-title":"Exogenous sex hormones, menstrual and reproductive history, and risk of non-melanoma skin cancer among women: a systematic literature review and meta-analysis","volume":"11","author":"Caini","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.contraception.2025.110869_bib13","first-page":"379","article-title":"Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer?","volume":"23","author":"Birch-Johansen","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.contraception.2025.110869_bib14","first-page":"274","article-title":"Reproductive factors, exogenous hormone use, and risk of B-cell non-Hodgkin lymphoma in a cohort of women from the European Prospective Investigation into Cancer and Nutrition","volume":"188","author":"Costas","year":"2019","journal-title":"Am\u00a0J\u00a0Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib15","first-page":"181","article-title":"Reproductive factors and non-Hodgkin lymphoma: a systematic review","volume":"92","author":"Costas","year":"2014","journal-title":"Crit\u00a0Rev\u00a0Oncol\/Hematol"},{"key":"10.1016\/j.contraception.2025.110869_bib16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ijc.25730","article-title":"Oral contraceptives, menopausal hormone therapy use and risk of B\u2010cell non\u2010Hodgkin lymphoma in the California Teachers Study","volume":"129","author":"Lu","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/bjc.2013.507","article-title":"Exogenous hormone use, reproductive history and risk of adult myeloid leukaemia","volume":"109","author":"Poynter","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib18","first-page":"580.e1","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am\u00a0J\u00a0Obstet\u00a0Gynecol"},{"key":"10.1016\/j.contraception.2025.110869_bib19","first-page":"151","article-title":"Hormonal and reproductive factors and risk of myeloproliferative neoplasms in postmenopausal women","volume":"25","author":"Leal","year":"2016","journal-title":"Cancer Epidemiol\u00a0Biomarkers Prev"},{"key":"10.1016\/j.contraception.2025.110869_bib20","first-page":"432.e1","article-title":"Sexuality- and fertility-related issues in women after allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Forgeard","year":"2021","journal-title":"Transplant\u00a0Cell\u00a0Ther"},{"key":"10.1016\/j.contraception.2025.110869_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/GME.0000000000002275","article-title":"Primary ovarian insufficiency: a toolkit for the busy clinician","volume":"31","author":"Kapoor","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2025.110869_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/13697137.2024.2423213","article-title":"Evidence-based guideline: premature ovarian insufficiency\u2020\u2021","volume":"27","author":"ESHRE, ASRM, CREWHIRL and IMS Guideline Group on","year":"2024","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2025.110869_bib23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1592\/phco.31.11.1092","article-title":"Management of menorrhagia associated with chemotherapy\u2010induced thrombocytopenia in women with hematologic malignancy","volume":"31","author":"Bates","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.contraception.2025.110869_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/bjc.2016.345","article-title":"Reproductive and menstrual factors and colorectal cancer incidence in the Women\u2019s Health Initiative Observational Study","volume":"116","author":"Murphy","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2407-14-371","article-title":"Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability","volume":"14","author":"Br\u00e4ndstedt","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib26","first-page":"65","article-title":"Nonlinear reduction in risk for colorectal cancer by oral contraceptive use: a meta-analysis of epidemiological studies","volume":"26","author":"Luan","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.contraception.2025.110869_bib27","first-page":"1047","article-title":"Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis","volume":"32","author":"Harewood","year":"2021","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.contraception.2025.110869_bib28","first-page":"229","article-title":"Hormonal and reproductive factors and reduction in the risk of colorectal cancer","volume":"29","author":"Rennert","year":"2020","journal-title":"Eur\u00a0J\u00a0Cancer Prev"},{"key":"10.1016\/j.contraception.2025.110869_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkac042","article-title":"Reproductive factors and colorectal cancer risk: a population-based case-control study","volume":"6","author":"Amitay","year":"2022","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1016\/j.contraception.2025.110869_bib30","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2105\/AJPH.2016.303349","article-title":"Exogenous hormone use: oral contraceptives, postmenopausal hormone therapy, and health outcomes in the nurses\u2019 health study","volume":"106","author":"Bhupathiraju","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2025.110869_bib31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.pan.2020.07.398","article-title":"Gynecological and reproductive factors and the risk of pancreatic cancer: a case-control study","volume":"20","author":"Archibugi","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.contraception.2025.110869_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206358","article-title":"Hormonal contraceptive use and risk of pancreatic cancer\u2014a cohort study among premenopausal women","volume":"13","author":"Butt","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.contraception.2025.110869_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ijc.31302","article-title":"Hormonal factors and pancreatic cancer risk in women: the Malm\u00f6 Diet and\u00a0Cancer\u00a0Study","volume":"143","author":"Andersson","year":"2018","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.contraception.2025.110869_bib34","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/MPA.0000000000000635","article-title":"Menstrual and reproductive factors, hormone use, and risk of pancreatic cancer: analysis from the International Pancreatic Cancer Case\u2013Control Consortium (PanC4)","volume":"45","author":"Lujan-Barroso","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.contraception.2025.110869_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000177","article-title":"Relationship between female hormonal and menstrual factors and pancreatic cancer: a meta-analysis of observational studies","volume":"94","author":"Tang","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.contraception.2025.110869_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MPA.0b013e31820bf986","article-title":"Reproductive and hormonal factors and pancreatic cancer risk in women","volume":"40","author":"Lucenteforte","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.contraception.2025.110869_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CLEP.S268556","article-title":"Reproductive factors, use of exogenous hormones, and pancreatic cancer incidence: the Norwegian Women and Cancer Study","volume":"13","author":"Alvarez","year":"2021","journal-title":"CLEP"},{"key":"10.1016\/j.contraception.2025.110869_bib38","first-page":"378","article-title":"Female reproductive factors, exogenous hormone use, and pancreatic cancer risk: the Japan Public Health Center-based prospective study","volume":"26","author":"Teng","year":"2017","journal-title":"Eur\u00a0J\u00a0Cancer Prev"},{"key":"10.1016\/j.contraception.2025.110869_bib39","first-page":"1403","article-title":"Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS","volume":"178","author":"Lee","year":"2013","journal-title":"Am\u00a0J\u00a0Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/dote.12349","article-title":"Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis: Esophageal cancer risk","volume":"29","author":"Wang","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.contraception.2025.110869_bib41","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/ijc.28869","article-title":"Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta\u2010analysis","volume":"135","author":"Lagergren","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib42","first-page":"20","article-title":"Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis","volume":"21","author":"Camargo","year":"2012","journal-title":"Cancer Epidemiol\u00a0Biomarkers\u00a0Prev"},{"key":"10.1016\/j.contraception.2025.110869_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.110869_bib44","series-title":"Combined estrogen-progestogen contraceptives","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2018"},{"key":"10.1016\/j.contraception.2025.110869_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001619","article-title":"Oral contraceptives use and liver cancer risk: a dose\u2013response meta-analysis of observational studies","volume":"94","author":"An","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.contraception.2025.110869_bib46","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bjc.2015.58","article-title":"Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project","volume":"112","author":"McGlynn","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.1979.03300070040020","article-title":"Epidemiology of hepatocellular adenoma: the role of oral contraceptive use","volume":"242","author":"Rooks","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2025.110869_bib48","first-page":"194","article-title":"Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study","volume":"3","author":"Heinemann","year":"1998","journal-title":"Eur\u00a0J\u00a0Contracept\u00a0Reprod\u00a0Health Care"},{"key":"10.1016\/j.contraception.2025.110869_bib49","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/ijc.34508","article-title":"Female reproductive and hormonal factors and lung cancer mortality among never\u2010smokers: a prospective cohort study of 287 408 Chinese women","volume":"152","author":"Cheng","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-5793(96)00782-X","article-title":"ER\u03b2: identification and characterization of a novel human estrogen receptor","volume":"392","author":"Mosselman","year":"1996","journal-title":"FEBS Letters"},{"key":"10.1016\/j.contraception.2025.110869_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0169-5002(02)00039-9","article-title":"Expression of estrogen receptors \u03b1 and \u03b2 in human lung tissue and cell lines","volume":"37","author":"Mollerup","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib52","first-page":"979","article-title":"The significance of estrogen receptor \u03b2 in 301 surgically treated non\u2013small cell lung cancers","volume":"130","author":"Wu","year":"2005","journal-title":"J\u00a0Thorac\u00a0Cardiovasc\u00a0Surg"},{"key":"10.1016\/j.contraception.2025.110869_bib53","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1200\/JCO.2007.13.3975","article-title":"Reproductive factors, hormone use, estrogen receptor expression and risk of non\u2013small-cell lung cancer in women","volume":"25","author":"Schwartz","year":"2007","journal-title":"JCO"},{"key":"10.1016\/j.contraception.2025.110869_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jwh.2009.1434","article-title":"Hormone therapy and risk of lung cancer: a meta-analysis","volume":"19","author":"Oh","year":"2010","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.contraception.2025.110869_bib55","first-page":"1004","article-title":"Hormone use, reproductive history, and risk of lung cancer: the women\u2019s health initiative studies","volume":"10","author":"Schwartz","year":"2015","journal-title":"J\u00a0Thorac\u00a0Oncol"},{"key":"10.1016\/j.contraception.2025.110869_bib56","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/ijc.25434","article-title":"Reproductive and hormonal factors and the risk of nonsmall cell lung cancer","volume":"128","author":"Meinhold","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib57","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/bjc.2013.506","article-title":"Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO)","volume":"109","author":"Pesatori","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib58","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/ijc.27926","article-title":"Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study","volume":"132","author":"Pesatori","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib59","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/ijc.33405","article-title":"Hormonal factors in association with lung cancer among Asian women: a pooled analysis from the International Lung Cancer Consortium","volume":"148","author":"Jin","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib60","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/jnci\/djp415","article-title":"Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003","volume":"101","author":"Deltour","year":"2009","journal-title":"JNCI J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2025.110869_bib61","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3171\/jns.2000.93.6.0932","article-title":"The impact of age and gender on the incidence of glial tumors in New York state from 1976\u20131995","volume":"93","author":"McKinley","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.contraception.2025.110869_bib62","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.11578","article-title":"Incidence trends of adult primary intracerebral tumors in four Nordic countries","volume":"108","author":"L\u00f6nn","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib63","first-page":"1007","article-title":"A pooled multisite analysis of the effects of female reproductive hormones on glioma risk","volume":"25","author":"Krishnamachari","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.contraception.2025.110869_bib64","article-title":"Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies","volume":"8","author":"Qi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.contraception.2025.110869_bib65","first-page":"697","article-title":"Brain tumors and hormonal factors: review of the epidemiological literature","volume":"22","author":"Cowppli-Bony","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.contraception.2025.110869_bib66","first-page":"901","article-title":"Joint associations between genetic variants and reproductive factors in glioma risk among women","volume":"174","author":"Wang","year":"2011","journal-title":"Am\u00a0J\u00a0Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-014-1427-0","article-title":"Reproductive factors and risk of primary brain tumors in women","volume":"118","author":"Anic","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.contraception.2025.110869_bib68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11060-017-2725-0","article-title":"Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies","volume":"137","author":"Lan","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.contraception.2025.110869_bib69","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.wneu.2020.11.175","article-title":"Relationship between oral contraceptives and the risk of gliomas and meningiomas: a dose-response meta-analysis and systematic review","volume":"147","author":"Yang","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.contraception.2025.110869_bib70","first-page":"677","article-title":"Hormonal contraceptive use and risk of glioma among younger women: a nationwide case\u2013control study","volume":"79","author":"Andersen","year":"2015","journal-title":"Br\u00a0J Clin\u00a0Pharmacol"},{"key":"10.1016\/j.contraception.2025.110869_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.contraception.2025.110869_bib72","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/cancers15030980","article-title":"Hormone receptor expression in meningiomas: a systematic review","volume":"15","author":"Agopiantz","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.contraception.2025.110869_bib73","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1227\/NEU.0b013e31826adf65","article-title":"Meningiomas in pregnancy: a clinicopathologic study of 17 cases","volume":"71","author":"Lusis","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.contraception.2025.110869_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3171\/2014.12.JNS142112","article-title":"Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report","volume":"124","author":"Kerschbaumer","year":"2016","journal-title":"JNS"},{"key":"10.1016\/j.contraception.2025.110869_bib75","first-page":"1","article-title":"Postpartum regression of a presumed cavernous meningioma","volume":"2016","author":"Phang","year":"2016","journal-title":"Case Rep\u00a0Oncol\u00a0Med"},{"key":"10.1016\/j.contraception.2025.110869_bib76","doi-asserted-by":"crossref","first-page":"e1261","DOI":"10.1016\/j.wneu.2018.03.187","article-title":"Houdini tumor: case report and literature review of pregnancy-associated meningioma","volume":"114","author":"Chakravarthy","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.contraception.2025.110869_bib77","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/neuonc\/noz005","article-title":"Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: the multiethnic cohort","volume":"21","author":"Muskens","year":"2019","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.contraception.2025.110869_bib78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3171\/2012.9.JNS12811","article-title":"Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females: clinical article","volume":"118","author":"Claus","year":"2013","journal-title":"JNS"},{"key":"10.1016\/j.contraception.2025.110869_bib79","first-page":"629","article-title":"Risk of brain tumors associated with exposure to exogenous female sex hormones","volume":"164","author":"Wigertz","year":"2006","journal-title":"Am\u00a0J\u00a0Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canep.2011.08.003","article-title":"Hormonal therapies and meningioma: is there a link?","volume":"36","author":"Cea-Soriano","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib81","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.bjc.6604445","article-title":"Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort","volume":"99","author":"Benson","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib82","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3171\/jns.2003.99.5.0848","article-title":"Sex steroid hormone exposures and risk for meningioma","volume":"99","author":"Jhawar","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.contraception.2025.110869_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078078","article-title":"Use of progestogens and the risk of intracranial meningioma: national case-control study","volume":"384","author":"Roland","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.110869_bib84","series-title":"Cyproterone-containing medicinal products - referral","author":"European Medicines Agency","year":"2024"},{"key":"10.1016\/j.contraception.2025.110869_bib85","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awy108","article-title":"The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment","volume":"141","author":"Nota","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.contraception.2025.110869_bib86","first-page":"599","article-title":"The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses\u2019 Health Study and Nurses\u2019 Health Study II","volume":"49","author":"Abufaraj","year":"2020","journal-title":"Int\u00a0J\u00a0Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib87","first-page":"449","article-title":"Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma","volume":"27","author":"Kabra","year":"2018","journal-title":"Eur\u00a0J\u00a0Cancer Prev"},{"key":"10.1016\/j.contraception.2025.110869_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102171","article-title":"Reproductive and external hormonal factors and the risk of renal cell cancer in the Netherlands Cohort Study","volume":"79","author":"Schouten","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib89","first-page":"1368","article-title":"Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010","volume":"177","author":"Karami","year":"2013","journal-title":"Am\u00a0J\u00a0Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib90","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.canep.2011.05.009","article-title":"Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study","volume":"35","author":"Schonfeld","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib91","first-page":"418","article-title":"Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer","volume":"7","author":"Braganza","year":"2014","journal-title":"Cancer Prev\u00a0Res"},{"key":"10.1016\/j.contraception.2025.110869_bib92","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canep.2017.04.001","article-title":"Hormonal and reproductive risk factors of papillary thyroid cancer: a population-based case-control study in France","volume":"48","author":"Cordina-Duverger","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.contraception.2025.110869_bib93","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1007\/s13277-015-3165-0","article-title":"Increased risk of papillary thyroid cancer related to hormonal factors in women","volume":"36","author":"Wang","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.contraception.2025.110869_bib94","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/ijc.29067","article-title":"Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study","volume":"136","author":"Zamora\u2010Ros","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2025.110869_bib95","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1002\/hed.25945","article-title":"Reproductive factors and thyroid cancer risk: meta\u2010analysis","volume":"41","author":"Mannathazhathu","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.contraception.2025.110869_bib96","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2011.07.007","article-title":"Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk","volume":"310","author":"Langevin","year":"2011","journal-title":"Cancer Letters"},{"key":"10.1016\/j.contraception.2025.110869_bib97","first-page":"1167","article-title":"Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case\u2013control study 1988\u20132009","volume":"25","author":"Wagner","year":"2014","journal-title":"Cancer Causes Control"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:12:35Z","timestamp":1762117955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":97,"alternative-id":["S0010782425000605"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110869","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 3 \u2013\u00a0Skin, blood, gastrointestinal, liver, lung, central nervous system, and other cancers: Joint with the Society of Gynecologic Oncology","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110869"}}